Dysregulation of the PI3K/Akt pathway occurs in up to 88% of GBM tumors and Akt, also known as protein kinase B, is a serine/threonine kinase that plays a crucial role in promoting chemoresistance in GBM cells [34]. This evidence concerns the gene MARK2 and glioblastoma.